Very true. I just hope they get on their horse with at least one clinical trial. Obviously the investor base is getting impatient. We really haven't had any news on clinical trials in about a year. That's too long. They are spending too much time and resources on hiring so-and-so and adding such-and-such technology. But in the end, they are a biotech/drug company and they need to bring a product to market.
News 
Market Data 
Discover 
AI
